Tecartus यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantle cell - antineoplastična sredstva - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Lartruvo यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

lartruvo

eli lilly nederland b.v. - olaratumab - sarcoma - antineoplastična sredstva - lartruvo je naveden v kombinaciji z doksorubicinom za zdravljenje odraslih bolnikov s napreden mehkih tkiv sarkom, ki niso mogoče kurativno zdravljenje z operacijo ali radioterapijo in ki niso bili predhodno obdelani z doksorubicinom (glej oddelek 5.

Natrijev klorid Fresenius Kabi 9 mg/ml vehikel za parenteralno uporabo स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

natrijev klorid fresenius kabi 9 mg/ml vehikel za parenteralno uporabo

fresenius kabi espana s.a. - natrijev klorid - vehikel za parenteralno uporabo - natrijev klorid 9 mg / 1 ml - raztopine in pripravki za redčenje, vključno s tekočinami za izpiranje